Focus Partners Wealth
IMMX icon

Focus Partners Wealth’s Immix Biopharma IMMX Stock Holding History

Focus Partners Wealth’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,900
Closed -$24.9K – 2749
2025
Q3 		$24.9K Hold
11,900
– – ﹤0.01% 2179
2025
Q2 		$24.6K Hold
11,900
– – ﹤0.01% 2001
2025
Q1 		$20K Hold
11,900
– – ﹤0.01% 1873
2024
Q4 		$26.2K Hold
11,900
– – ﹤0.01% 1843
2024
Q3 		$17.7K Hold
11,900
– – ﹤0.01% 1558
2024
Q2 		$24K Buy
+11,900
New +$27.3K ﹤0.01% 1216

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Focus Partners Wealth's IMMX Position: Q4 2025 in Review

Focus Partners Wealth sold out of Immix Biopharma (IMMX) in Q4 2025, closing a stake of 11,900 shares — an estimated $24.9K sold.

Focus Partners Wealth first reported a position in IMMX in Q2 2024 and held it in 6 quarters. The position peaked at $26.2K in Q4 2024. 67 funds tracked by Wall St. Rank hold IMMX as of Q4 2025.

  • Focus Partners Wealth reported no remaining Immix Biopharma position as of Q4 2025 after selling out during the quarter.
  • Focus Partners Wealth sold 11,900 Immix Biopharma shares in Q4 2025, an estimated $24.9K.
  • Focus Partners Wealth first reported a position in Immix Biopharma in Q2 2024 and held it in 6 quarters.
  • Focus Partners Wealth's Immix Biopharma position peaked at $26.2K in Q4 2024.
  • 67 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2025.

Based on Focus Partners Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.